Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Senti Biosciences
(NASDAQ:SNTI)
Intraday
$0.299
0
[0.00%]
15 minutes delayed
Get Report
Watch
Perks
Buy
Compare Brokers
$0.299
0
[0.00%]
Last update: 6:07PM
Get Real Time Here
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Senti Biosciences Stock (NASDAQ:SNTI)
Senti Biosciences Stock (NASDAQ: SNTI)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, March 21, 2024
Senti Biosciences Q4 2023 GAAP EPS $(0.42) Misses $(0.28) Estimate
Benzinga Newsdesk
-
Mar 21, 2024, 4:11PM
Tuesday, January 23, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
-
Jan 23, 2024, 4:31PM
Monday, January 22, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Jan 22, 2024, 8:05AM
Friday, January 05, 2024
Senti Biosciences Said Reducing Its Workforce By ~37% As Part Of Prioritizing Its Investment In Lead Clinical Program
Charles Gross
-
Jan 5, 2024, 4:07PM
Monday, December 25, 2023
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Dec 25, 2023, 8:05AM
Friday, December 22, 2023
Senti Biosciences shares are trading higher after the company announced FDA clearance for its IND application for SENTI-202 for the treatment of relapsed or refractory hematologic malignancies including acute myeloid leukemia.
Benzinga Newsdesk
-
Dec 22, 2023, 1:32PM
Why Is Blood Cancer Focused Senti Biosciences Stock Trading Higher Today?
Vandana Singh
-
Dec 22, 2023, 10:12AM
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Dec 22, 2023, 8:07AM
Senti Biosciences Announces FDA Clearance Of IND Application For SENTI-202 For The Treatment Of Relapsed Or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia
Benzinga Newsdesk
-
Dec 22, 2023, 6:36AM
Monday, December 18, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Dec 18, 2023, 4:31PM
Tuesday, December 12, 2023
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
-
Dec 12, 2023, 4:31PM
Thursday, December 07, 2023
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Dec 7, 2023, 4:31PM
Monday, November 13, 2023
Senti Biosciences Q3 2023 EPS $(0.34) Up From $(0.38) YoY, Revenue $338K
Benzinga Newsdesk
-
Nov 13, 2023, 5:42PM
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Nov 13, 2023, 4:31PM
Wednesday, November 08, 2023
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Nov 8, 2023, 12:31PM
Tuesday, November 07, 2023
Crude Oil Falls Sharply; Datadog Shares Spike Higher
Lisa Levin
-
Nov 7, 2023, 2:30PM
Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
-
Nov 7, 2023, 1:10PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Nov 7, 2023, 12:31PM
Nasdaq Jumps 100 Points; US Trade Deficit Widens In September
Lisa Levin
-
Nov 7, 2023, 12:05PM
US Stocks Mixed; D.R. Horton Earnings Top Views
Lisa Levin
-
Nov 7, 2023, 9:46AM
Senti Biosciences shares are trading higher after the company reported a new strategic collaboration with Celest Therapeutics for the clinical development of SENTI-301A in China. Senti is eligible to receive up to $156 million in milestones and royalties.
Benzinga Newsdesk
-
Nov 7, 2023, 9:34AM
Why Is Cell & Gene Therapy-Focused Senti Biosciences Stock Trading Higher Today?
Vandana Singh
-
Nov 7, 2023, 9:28AM
Why Alteryx Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Nov 7, 2023, 8:28AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
-
Nov 7, 2023, 8:06AM
Monday, November 06, 2023
Senti Biosciences shares are trading higher after the company reported a new strategic collaboration with Celest Therapeutics for the clinical development of SENTI-301A in China. Senti is eligible to receive up to $156 million in milestones and royalties.
Benzinga Newsdesk
-
Nov 6, 2023, 5:04PM
Senti Bio Announces New Strategic Collaboration With Celest Therapeutics For Clinical Development Of SENTI-301A In China; Senti Bio Eligible To Receive Up To $156M In Milestones And Royaltie
Benzinga Newsdesk
-
Nov 6, 2023, 4:41PM
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Nov 6, 2023, 4:31PM
Tuesday, October 31, 2023
Senti Bio Announces Multiple Data Presentations At The Society For Immunotherapy Of Cancer Annual Meeting
Benzinga Newsdesk
-
Oct 31, 2023, 9:07AM
Monday, October 09, 2023
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Oct 9, 2023, 9:06AM
Friday, October 06, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Oct 6, 2023, 5:31PM
Wednesday, October 04, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
-
Oct 4, 2023, 5:31PM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Oct 4, 2023, 9:06AM
Why Brooge Energy Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Oct 4, 2023, 8:03AM
Tuesday, October 03, 2023
Senti Biosciences Has Received A Notice Of Allowance For Its U.S. Patent Application 17/338,528 Titled "Chimeric Receptors And Methods Of Use Thereof (For Treatment Of Acute Myeloid Leukemia)"
Benzinga Newsdesk
-
Oct 3, 2023, 1:09PM
Friday, September 29, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Sep 29, 2023, 5:31PM
Tuesday, September 19, 2023
Why Elutia Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Sep 19, 2023, 7:59AM
Monday, September 18, 2023
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Sep 18, 2023, 1:31PM
Thursday, September 14, 2023
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Sep 14, 2023, 5:31PM
Friday, September 08, 2023
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Sep 8, 2023, 9:06AM
Tuesday, August 15, 2023
Chardan Capital Reiterates Buy on Senti Biosciences, Maintains $6 Price Target
Benzinga Newsdesk
-
Aug 15, 2023, 4:25AM
Friday, August 11, 2023
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Aug 11, 2023, 9:06AM
Senti Biosciences Q2 EPS $(0.42) Beats $(0.48) Estimate, Sales $937.00K Beat $500.00K Estimate
Benzinga Newsdesk
-
Aug 11, 2023, 8:41AM
Thursday, August 10, 2023
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
Aug 10, 2023, 9:06AM
Thursday, July 06, 2023
Why VBI Vaccines Are Trading Lower By Over 23%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Jul 6, 2023, 8:03AM
Thursday, June 22, 2023
Board Member at Senti Biosciences Acquires Company Stock Options Worth 62,500 Shares
Benzinga Insights
-
Jun 22, 2023, 11:02AM
Senti Biosciences Board Member Awarded $63K Worth of Stock Options
Benzinga Insights
-
Jun 22, 2023, 11:02AM
Senti Biosciences Director Awarded $63K Worth of Stock Options
Benzinga Insights
-
Jun 22, 2023, 11:02AM
Thursday, May 11, 2023
Chardan Capital Maintains Buy on Senti Biosciences, Lowers Price Target to $6
Benzinga Newsdesk
-
May 11, 2023, 1:08PM
Tuesday, May 09, 2023
Senti Biosciences Q1 EPS $(0.42) Beats $(0.43) Estimate
Benzinga Newsdesk
-
May 9, 2023, 5:11PM
Thursday, April 20, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Apr 20, 2023, 12:25PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch